🟢 Cue Biopharma is trading 6.4% up today following a reverse stock split and $50 million private placement

Cue Biopharma is trading 6.4% up at $32.90 in pre-market action as the market reacts to significant changes in the company's capital structure.

• The company recently executed a 1-for-30 reverse stock split and a $50 million private placement, fundamentally changing its share structure and capital position.
• The stock continues to experience high volatility as investors reassess valuation and liquidity following a sharp drop on July 13, 2026.